PULMONARY TUBERCULOSIS
Multi–drug-resistant Tuberculosis (MDR TB):
·
Multi–drug-resistant Tuberculosis (MDR
TB): a comprehensive review -
http://www.emedicine.com/emerg/topic618.htm
·
WHO: MDR TB: Frequently asked questions (FAQ's) -
http://www.who.int/tb/dots/dotsplus/faq/en/index.html
·
WHO: Guidelines for the
programmatic management of drug-resistant tuberculosis -
http://whqlibdoc.who.int/publications/2006/9241546956_eng.pdf
·
WHO and the International
Union Against Tuberculosis and Lung Disease: Guidelines for surveillance of drug
resistance in tuberculosis -
http://whqlibdoc.who.int/publications/2003/9241546336.pdf
·
WHO: DOTS-Plus and the Green Light Committee -
http://www.who.int/tb/dots/dotsplus/management/en/index.html
·
WHO: Procurement manual for the Dots-Plus Projects Approved by the
Green Light Committee -
http://whqlibdoc.who.int/hq/2004/WHO_HTM_TB_2003.328_Rev.1.pdf
·
WHO: Instructions for applying to the Green Light Committee for
access to Second-line Antituberculosis Drugs -
http://whqlibdoc.who.int/hq/2001/WHO_CDS_TB_2001.286_Rev.1.pdf
Pulmonary TB & HIV:
Measures:
Lab Studies:
Tuberculin Skin Test:
Acid-fast bacillus (AFB) smear, and culture and sensitivity (C/S) test:
Chest X-Ray:
Lung Function Tests:
Infant Pulmonary Function Testing:
Diagnostic Flexible Bronchoscopy:
Bronchoalveolar Lavage (BAL):
Gastric Lavage:
Biopsy and Histopathology:
Statistics:
Prevention of Tuberculosis:
Discharge
Planning for the Respiratory Care Patient:
Document Author: Dr. Fazal Danish
Document Created: 11th April 2006
Document Edits:
|